{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8460933", "DateCompleted": {"Year": "1993", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "20", "Issue": "2", "PubDate": {"Year": "1993", "Month": "Feb"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "The importance of light in the anti-HIV effect of hypericin.", "Pagination": {"StartPage": "173", "EndPage": "178", "MedlinePgn": "173-8"}, "Abstract": {"AbstractText": ["The requirement for light in the anti-HIV-1 activity of hypericin was investigated. The hypericin concentration-dependence and light dosage-dependence of the reaction were measured. Under conditions in which hypericin caused substantial inactivation of HIV-1, there was a strict requirement for visible light. Only when the concentration of hypericin approached the cytotoxic level was there an apparent light-independent antiviral effect. This strict light-requirement for the antiviral effect could explain some of the apparently discrepant results reported by other workers. Furthermore if hypericin is contemplated for use in humans, the importance of light must be considered."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medical Microbiology, University of British Columbia, Vancouver, Canada."}], "LastName": "Hudson", "ForeName": "J B", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Harris", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Towers", "ForeName": "G H", "Initials": "GH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anthracenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "HIV Core Protein p24"}, {"RegistryNumber": "5QD5427UN7", "NameOfSubstance": "Perylene"}, {"RegistryNumber": "7V2F1075HD", "NameOfSubstance": "hypericin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Anthracenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cytopathogenic Effect, Viral"}, {"QualifierName": ["metabolism"], "DescriptorName": "HIV Core Protein p24"}, {"QualifierName": ["drug effects"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Light"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Perylene"}, {"QualifierName": [], "DescriptorName": "Photochemistry"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1993", "Month": "2", "Day": "1"}, {"Year": "1993", "Month": "2", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "2", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8460933", "10.1016/0166-3542(93)90006-5", "0166-3542(93)90006-5"]}}]}